This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Compliance & Legal, Biotech & Pharma
Porzio Life Sciences

Best Guidance for Managing Risks and Avoiding Enforcement Actions | Porzio Life Sciences

Posted by on 13 December 2021
Share this article

In this compilation, Porzio Life Sciences provides recent updates from Porzio Compliance Digest highlighting the latest information on Open Payments, Anti-Kickback Violations and Fraud Enforcement Actions. Click the Download Now button above to read the piece, which features the following updates:

  • Accreditation Council for Continuing Medical Education Guidelines Go Into Effect January 2022
  • Centers for Medicare and Medicaid Services Has Posted On Its Open Payments Website The 2022 List Of Teaching Hospitals
  • Device Manufacturer and Executives Charged with Anti-Kickback Violations
  • Department of Justice Announces National Healthcare Fraud Enforcement Action

Click the Download Now button above to read the piece.


Share this article